DRAGONFLY is a new tool for molecular design that utilizes a drug-target interactome and deep learning models to generate ligand- and structure-based designs. The interactome contains over 360,000 ligands and 2989 targets, and the deep learning models accept molecular graphs as input to generate designs with desired bioactivity and physicochemical properties.